Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Invitae Congenital Myopathy Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 61 | 37 |
|
Invitae Comprehensive Neuromuscular Disorders Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 353 | 208 |
|
Invitae Cardiomyopathy Comprehensive Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 198 | 82 |
|
Invitae Arrhythmia and Cardiomyopathy Comprehensive Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 239 | 100 |
|
Invitae Hypertrophic Cardiomyopathy Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 75 | 59 |
|
Cincinnati Children's Hospital Medical Center Genetics and Genomics Diagnostic Laboratory Cincinnati Children's Hospital Medical Center United States | 1 | 1 |
|
Hypertrophic Cardiomyopathy via the MYL2 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Cardiomyopathy, familial hypertrophic 10 (sequence analysis of MYL2 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Genologica Medica Spain | 172 | 59 |
|
Familial Hypertrophic Cardiomyopathy Panel Duzen Laboratories Duzen BBAGUAS Turkey | 5 | 5 |
|
Hypertrophic Cardiomyopathy Type 10 Genetiks Genetic Diagnosis Center Genetic Diseases Evaluation Center Turkey | 1 | 1 |
|
Hypertrophic Cardiomyopathy Panel, Sequencing ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories United States | 25 | 34 |
|
Arrhythmia & Cardiomyopathy Panel, Comprehensive CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 211 | 93 |
|
Cardiomyopathy Panel, Comprehensive CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 170 | 71 |
|
Cardiomyopathy Panel, Hypertrophic CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 85 | 35 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 2 | 1 |
|
Cardiomyopathy, familial hypertrophic: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 30 | 26 |
|
Fulgent Genetics United States | 186 | 61 |
|
ACMG Secondary Findings (Medically Actionable Genes, Including Cardio and Cancer) NGS Panel Fulgent Genetics United States | 177 | 59 |
|
Comprehensive Cardiomyopathy NGS Panel Fulgent Genetics United States | 450 | 128 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.